Your institution may have access to this item. Find your institution then sign in to continue.
Title
HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support.
Authors
Bewick M; Conlon M; Gerard S; Lee H; Parissenti AM; Zhang L; Glück S; Lafrenie RM
Publication
Bone marrow transplantation, 2001, Vol 27, Issue 8, p847